Medicare Part D coverage · 24 · RxCUI 2605950
24 HR venlafaxine 112.5 MG Extended Release Oral Tablet
Per the CMS 2026 Part D formulary file, 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet is covered by 1,457 Medicare Part D plans (28.8% of enrollable products), averaging Tier 3.5, with prior authorization required on 1.2% of covering formularies.
- 28.8%
- Plan coverage
- 1,457
- Plans covering
- T3.5
- Avg tier
- 1.2%
- Prior auth required
What the CMS Formulary Data Shows for 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet
Per the CMS 2026 Part D formulary file, 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet (RxNorm concept RXCUI 2605950, generic name 24) appears on 85 distinct formulary files spanning 1,457 Medicare Part D plan offerings - 28.8% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 4, with a cross-plan average of Tier 3.5.
Real-world access to 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet depends on utilization management as much as tier placement: 1.2% of covering formularies require prior authorization. 5.9% require step therapy. 87.1% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet today.
Coverage Details
- Formularies covering
- 85
- Plans covering
- 1,457
- Coverage rate
- 28.8%
- Tier range
- Tier 1 – Tier 4
- Average tier
- Tier 3, Preferred Brand
Restrictions
- Prior authorization required
- 1.2% of formularies
- Step therapy required
- 5.9% of formularies
- Quantity limits
- 87.1% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
| Hamaspik Medicare Select (HMO D-SNP) | Hamaspik, Inc. | T1 | No | $34.50 | NY |
| MCS Classicare RxMax (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Ideal (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Efectivo (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Essential (HMO-POS) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Progreso (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Primero (HMO C-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Firme (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare En Tu Hogar (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Hero (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Total (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare InteliCare (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Maximo (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Excede (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Estrella (HMO) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino Superior (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| MCS Classicare Platino 185 (HMO D-SNP) | MCS Advantage, Inc. | T2 | No | $0 | PR |
| Healthy Mississippi Premier Advantage (HMO-POS) | Healthy Mississippi, Inc. | T2 | No | $0 | MS |
| Freedom VIP Care (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Savings (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom VIP Rewards (HMO C-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Savings (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond Rewards (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Optimum Diamond (HMO C-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
| Freedom Medi-Medi Partial (HMO D-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Freedom Medi-Medi Full (HMO D-SNP) | Freedom Health, Inc. | T3 | No | $0 | FL |
| Optimum Emerald Partial (HMO D-SNP) | Optimum Healthcare, Inc. | T3 | No | $0 | FL |
Showing top 50 of 100 plans.
Frequently Asked Questions
Is 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet covered by Medicare Part D?
Yes, 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet is covered by 1,457 Medicare Part D plans (28.8% of all Part D formularies).
What tier is 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet on Medicare Part D plans?
24 HR venlafaxine 112.5 MG Extended Release Oral Tablet averages Tier 3.5 across Part D plans, ranging from Tier 1 to Tier 4.
Does 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet require prior authorization?
1.2% of Part D formularies require prior authorization for 24 HR venlafaxine 112.5 MG Extended Release Oral Tablet. Step therapy: 5.9%. Quantity limits: 87.1%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
Similar prior-authorization rate
- oxycodone hydrochloride 30 MG Oral Tablet 1.2% PA
- ribavirin 200 MG Oral Tablet 1.2% PA
- 100 ML sodium chloride 9 MG/ML Injection 1.2% PA
- 10 ML magnesium sulfate 500 MG/ML Prefilled Syringe 1.2% PA
- 1000 ML glucose 50 MG/ML / potassium chloride 0.02 MEQ/ML / sodium chloride 2.25 MG/ML Injection 1.2% PA
- 1000 ML glucose 50 MG/ML / potassium chloride 0.04 MEQ/ML / sodium chloride 4.5 MG/ML Injection 1.2% PA